Paul Averback, MD, DABP, President and CEO
Dr. Paul Averback is the founder, CEO and President of Nymox. Dr. Averback has extensive firsthand knowledge of health care, including as an emergency room physician, family physician, clinic administrator and university Medical Faculty member. In addition to many issued and pending patents, Dr. Averback has published prolifically in the scientific and medical literature on subjects such as Alzheimer's disease, pharmaceuticals, neuropathology, neuroanatomy, diagnostics, vascular disease, oncology, cytology, congenital disease, embryology, geometrical probability and morphometry. Dr. Averback holds a Diploma of the American Board of Pathology with Special Competence in Neuropathology, was a Medical Research Council Postdoctoral Fellow at Cambridge University, England, and was on the Faculty of Medicine at McGill University.
Erik Danielsen, Chief Financial Officer
Erik Danielsen holds an MBA in Finance and Swiss Business Law from the University of Fribourg in Switzerland. He was formerly Senior Auditor for Price Waterhouse in Zurich and subsequently was Equity Strategist for Credit Suisse. He has been acting as an independent health care analyst and consultant, advising both young growth companies as well as private and industrial investors on a variety of subjects including company evaluations, equity financing and operational communication strategies over the past 20 years.
Randall Lanham, Director
Randall Lanham has been a director since 2006 and Secretary to Nymox since 2015, and in-house Corporate Counsel since 2015. Mr. Lanham has a BSc from the University of Delaware and JD (1991) from Whittier College School of Law, and is licensed in the state of California. Mr. Lanham has vast experience in both domestic and international corporate legal matters, as well as hands-on experience in business operations, regulatory matters, and mergers and acquisitions.
Suresh Kalbag, MD
Dr. Suresh Kalbag is Nymox's Director of CMC Operations. Dr. Kalbag received his Ph.D. from Loyola University and did postdoctoral research at Indiana University School of Medicine. Dr. Kalbag has extensive first-hand and senior management experience in Research, Process Development, Manufacturing and QC at prestigious companies including Beckman, SmithKline, Genentech, and others, including experience at Ciba Research Center (Novartis) and the University of Basel.
James G. Robinson, Director
James G. Robinson, is the CEO of Morgan Creek Productions, which for over 25 years, has continued to be one of the leading and most successful independent production entities in the film business. Under Robinson's leadership, Morgan Creek has produced an assortment of highly successful and critically acclaimed feature films.
Professor David Morse, Director
Professor David Morse, Ph.D. is a Professor at the University of Montreal and a world expert in the biochemistry, proteomics and genomics of cell function. Professor Morse has published extensively in the peer-reviewed scientific literature, including papers in journals such as Science, Nature, Cell, Proceedings of the National Academy of Science, and the Journal of Biological Chemistry.
Richard Cutler, Director
Richard Cutler is a graduate of Brigham Young University and Columbia University School of Law. Mr. Cutler has worked at several major national law firms, and in 1996, formed Cutler Law Group in Newport Beach, California and subsequently Atlanta, Georgia and Houston, Texas, a firm which specializes in corporate and securities law, as well as international business transactions.